| Filed On | Filing |
|---|---|
| 01 Mar 2022 |
8-K/A: Results of Operations and Financial Condition
SOUTH SAN FRANCISCO, CA., February 28, 2022 - Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today provided a corpo... |
Loading...